induration erythema; swelling; warmth; This serious case was reported by a other health professional via sales rep and described the occurrence of induration erythema in a 85-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On 07-JAN-2025, an unknown time after receiving Shingrix, the patient experienced induration erythema (Verbatim: induration erythema) (serious criteria GSK medically significant), swelling (Verbatim: swelling) and feeling of warmth (Verbatim: warmth). The outcome of the induration erythema, swelling and feeling of warmth were resolved. The reporter considered the induration erythema, swelling and feeling of warmth to be related to Shingrix. The company considered the induration erythema to be unrelated to Shingrix. The company considered the swelling and feeling of warmth to be related to Shingrix. Additional Information: GSK Receipt Date: 09-JAN-2025 The reporter reported that the patient received a first dose of Shingrix and had induration erythema, swelling, and warmth.; Sender’s Comments: Erythema induratum is an unlisted event which is considered unrelated to GSK vaccine Shingrix.